Pharmacyclics Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (35)

View All

Latest Posts

About This Stock More About This Stock
Follow This Strategy And Book Huge Returns In Biotech
Article By: Bret Jensen
Tuesday, September 8, 2015 4:13 PM EDT
One advantage large cap biotech growth stocks have over large growth stocks in other sectors is they are less dependent on global demand levels and are less subject to the whims of the currency market given their ultra-high gross margins.
In this article: MRK, AMGN, CELG, GILD, ABBV Also: MCD, PCYC
Read
5 Stock-Picking Secrets Of The Whales
Article By: Kevin Cook
Friday, August 14, 2015 8:18 PM EDT
The big, sideways "meat grinder" trading range this year is setting up some terrific opportunities in certain stocks and sectors. Because I still think we are headed to my target of S&P 2250 by year end.
In this article: VRX, SYNA, PCYC, AVGO, SWKS, ACHC, MBLY
Read
Notes From BIO 2015 #1 Recap And Biotechnology Trends-M&A, Precision Medicine
Article By: Rod Raynovich
Thursday, June 25, 2015 3:58 AM EDT
Many of the hottest stocks in 2015 are in “rare diseases” with multi-$B market caps with no approved products in the market.
In this article: BMRN, SRPT, BLUE, ABBV, PCYC, ILMN, VRX
Read
A Comparison Of Johnson & Johnson Versus Pfizer As A Long Term Play
Article By: Terry Chrisomalis
Wednesday, June 17, 2015 5:45 PM EDT
Johnson & Johnson is a better long term play than Pfizer for many reasons.
In this article: JNJ, PFE Also: PCYC, ACHN, GILD, AZN, MKGAY, RGEN, ISIS, BIIB
Read
Hot Biotech Sector: Mid-Caps Have Both M&A And Pipeline Premiums
Article By: Rod Raynovich
Wednesday, May 13, 2015 3:26 PM EDT
M&A has been a major driver of bio-pharmaceutical stocks and the buyout of Syngeva by Alexion for $8.4B last week showed that there is a lot of value in pipelines that fit with the acquirer.
In this article: VRX, ARIA, SGEN, ALKS, CLDX, VRTX Also: PCYC, ABBV, MRK, AMGN, GEVA, ACT, SNY, ALNY, FBT, CBST, ALXN
Read
All Posts

Latest Tweets for $PCYC

No tweets yet!

PARTNER HEADLINES